Hyperion Defi (HYPD) EBIT Margin Growth (1y) (2024 - 2026)

Hyperion Defi (HYPD) EBIT Margin Growth (1y) (2024 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBIT Margin Growth (1y) (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	-143.00
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	78.00
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	1,135.00
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	7,666.00
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	1,238.00
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	2,002.00
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	29,091.00
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-1,651.00
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	-3,558.00
10	Hyperion Defi	44.65 Mn	35.01 Mn	357,693.00	-

Download Data